• February 4, 2019
• 0

Six new medications have come significantly closer to European approvals having won the backing of the European Medicines Agency (EMA) human medicines committee (CHMP). The positive opinions come for Teva's Ajovy (fremanezumab),...

• January 30, 2019
• 0

NHS England has announced they will be recruiting an 'army' of 1,000 'social prescribers' to help patients live better and healthier lives as well as combat depression, loneliness and anxiety. According...

• January 24, 2019
• 0

A new report by Jannsen has highlighted the failure of mental health services in the UK in comparison with other parts of the health system and NHS. The report from...

• February 27, 2019
• 0

Yesterday - Tuesday 26th February - saw senators grilling CEOs of no less than seven pharma-giants on high prescription drug prices that are a burden on Medicare, Medicaid and millions...

• February 26, 2019
• 0

• February 25, 2019
• 0

Novartis has acquired rights to TQJ230 from Akcea Therapeutics, a novel cardiovascular drug that could become first-in-class and has the potential to treat million of patients. TQJ230 is based on the...

• February 25, 2019
• 0

Roche and Spark Therapeutics have announced they are to enter a definitive merger agreement for Roche to fully acquire Spark for $4.3bn - the first company to gain approval for...

• February 22, 2019
• 0

AbbVie and Voyager Therapeutics have entered into an exclusive global strategic collaboration and option agreement to develop and commercialise vectorised antibodies for the potential treatment of Parkinson's disease. The deal means that Voyager...

• February 21, 2019
• 0

Novo Nordisk has received U.S. FDA approval for Esperoct (turoctocog alfa peg, N8-GP) for the treatment of children and adults with haemophilia A. Today's decision permits physicians to prescribe the drug for...

• February 21, 2019
• 0

Pfizer and Eli Lilly have revealed more positive results for their non-opioid pain drug tanezumab - with significant improvements in chronic lower pack pain (CBLP). The results come from a phase III...

• February 21, 2019
• 0

Pfizer has won European Commission approval for its Avastin biosimilar Zirabev (bevacizumab). The approval comes on the back of data from the phase III REFLECTIONS B739-03 clinical comparative study which...

• February 21, 2019
• 0

Abbott and Novo Nordisk have begun a non-exclusive partnership to provide integrated digital solutions for patients with diabetes requiring insulin. The collaboration enables insulin data to be shared between Novo...

• February 20, 2019
• 0

New molecules developed at Toronto's Centre for Addiction and Mental Health have shown signifcant promise in their ability to reverse memory loss associated with depression and ageing. Not only do these molecules improve cognitive...